This Phase 2 trial tests whether delivering the anti-inflammatory drug dexamethasone directly around deep veins can prevent blood clots from returning after they are removed. The study involves 60 adults aged 18-89 who have had DVT symptoms for 14-60 days. Participants receive ei…
Phase: PHASE2 • Sponsor: Mercator MedSystems, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC